Multipotent Stem Cells are a type of adult or somatic stem cell with the ability to differentiate into a limited range of cell types within a specific tissue or organ. Unlike pluripotent stem cells, which can differentiate into cells of any embryonic germ layer, multipotent stem cells are more specialized and have a more restricted differentiation potential. Multipotent stem cells are found in various tissues throughout the body, including the bone marrow, adipose tissue, and the umbilical cord. The differentiation potential of multipotent stem cells is crucial for tissue homeostasis, repair, and regeneration. These cells contribute to the replenishment of specific cell types lost due to normal turnover, injury, or disease. While not as versatile as pluripotent stem cells, multipotent stem cells are valuable in regenerative medicine and tissue engineering. They have been explored for their therapeutic potential in treating various conditions, including cardiovascular diseases, orthopedic injuries, and neurodegenerative disorders. Understanding the molecular mechanisms that regulate the differentiation of multipotent stem cells is essential for harnessing their regenerative capabilities. Ongoing research aims to elucidate these mechanisms and develop strategies to manipulate and utilize multipotent stem cells for therapeutic purposes.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States